← All candidates
35 insider filings on record.
35 filings on record.
AKBAAkebia Therapeutics, Inc.
NasdaqCM · Healthcare · $375.56M
$0.9160
+2.23% · Sep 18
35 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 15 sells
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$375.56M
Float
262.0M
98% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
—
Price / sales
1.6
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
30 more transactions on Pro →Context
Wall St
$3.80 avg target
+314.8% vs today · 5 analysts
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
2 of 4 quarters beat
Q2 '26−$0.03 act−$0.00
Q1 '26−$0.03 act−$0.01
Q4 '25−$0.05 act+$0.01
Q3 '25$0.00 act+$0.01
Coverage
Akebia Therapeutics Inc (AKBA) (Q2 2026) Earnings Call Highlights: Vafseo Surges 60% as VOICE ...GuruFocus.com · 08-06Akebia Therapeutics (AKBA) Reports Q2 Loss, Lags Revenue EstimatesZacks · 08-05Akebia Therapeutics Q2 Earnings Call HighlightsMarketBeat · 08-05Akebia Therapeutics, Inc. (AKBA) Strengthens Vafseo Patent Protection Through 2036Insider Monkey · 06-30
The file stays open
35 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice